Proposal to Amend Ontario Regulation 201/96 under the Ontario Drug Benefit Act and Regulation 935 under the Drug Interchangeability and ... Read More
News
27
Jul2015
20
Jul2015
PDCI & H3 Survey on Private Payer Product Listing Agreements Now “Closed” for Responses
As noted in the June 24th TargetPharma, ... Read More
24
Jun2015
PDCI & H3 Survey on Private Payer Product Listing Agreements Interest, Experience & Expectations
Private payers – the community of insurers, ... Read More
23
Jun2015
Australia’s Pharmaceutical Benefits Advisory Committee Recommends Substitution of Biosimilars
/ News, What's New
Currently in Canada, switching and substitutability between originator biologics and biosimilars has not been established, however that is not the ... Read More
19
Jun2015
INESSS is offering an opportunity for in-person meetings to manufacturers who have filed a submission by the deadline for drugs ... Read More
12
Jun2015
The Minister of Health and Social Services has authorized three updates to the List of Medications covered by the basic ... Read More
08
Jun2015
PDCI Market Access’s International Trends Series provides the results of an online survey conducted by PDCI between March 19, 2015 ... Read More
27
May2015
The BC Ministry of Health recently wrote to manufacturers to communicate updates to its drug review process and reimbursement submission ... Read More